IFLScience on MSN10h
New Breast Cancer Drug Kills Mouse Tumors In Single DoseMore testing is needed, but if the same results are seen in humans, it could transform treatment of the disease.
Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment ...
The true incidence of thrombosis among people who received targeted therapy for breast cancer is significantly higher than ...
The rising incidence of metastatic breast cancer (MBC) among young Indian women highlights the need for personalised care.
The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the body or cannot be surgically removed.
It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...
The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — ...
Verywell Health on MSN13h
How Legacy Projects Can Be Cathartic When Living With Metastatic Breast CancerLegacy projects can help someone with metastatic breast cancer leave behind a lasting impact that will be remembered after ...
News Medical on MSN2h
Genomic insights and new treatment paradigms related to HER2-low breast cancerA new review was published in Oncotarget's Volume 16 on January 20, 2025, titled "Evolving concepts in HER2-low breast cancer: Genomic insights, definitions, and treatment paradigms." ...
The clearance of Datroway comes months after the companies narrowed approval plans in lung cancer and opens up a market ...
The efficacy of immunotherapy against triple-negative breast cancer (TNBC) heavily relies on intratumoral infiltration of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback